Diefenbach, MD | NYU Langone Health

Dr. Catherine S. Diefenbach

Claim this profile

Laura and Isaac Perlmutter Cancer Center at NYU Langone

Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
12 reported clinical trials
26 drugs studied

Area of expertise

1Lymphoma
Catherine S. Diefenbach has run 10 trials for Lymphoma. Some of their research focus areas include:
Stage IV
CCND1 positive
t(11;14) positive
2Non-Hodgkin's Lymphoma
Catherine S. Diefenbach has run 7 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Stage IV
Stage III
CCND1 positive

Affiliated Hospitals

Image of trial facility.
Laura And Isaac Perlmutter Cancer Center At NYU Langone
Image of trial facility.
NYU Winthrop Hospital

Clinical Trials Catherine S. Diefenbach is currently running

Image of trial facility.

CC-99282 + Anti-Lymphoma Agents

for Non-Hodgkin's Lymphoma

This trial is testing a new drug, CC-99282, for patients with certain types of lymphoma who haven't responded to other treatments. Researchers are finding the safest dose and checking if it works better alone or with other drugs.
Recruiting1 award Phase 1 & 22 criteria
Image of trial facility.

Oral Azacitidine + R-miniCHOP

for Diffuse Large B-Cell Lymphoma

This phase II/III trial compares the side effects and activity of oral azacitidine in combination with the standard drug therapy (reduced dose rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisone \[R-miniCHOP\]) versus R-miniCHOP alone in treating patients 75 years or older with newly diagnosed diffuse large B cell lymphoma. R-miniCHOP includes a monoclonal antibody (a type of protein), called rituximab, which attaches to the lymphoma cells and may help the immune system kill these cells. R-miniCHOP also includes prednisone which is an anti-inflammatory medication and a combination of 3 chemotherapy drugs, cyclophosphamide, doxorubicin, and vincristine. These 3 chemotherapy drugs, as well as oral azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Combining oral azacitidine with R-miniCHOP may shrink the cancer or extend the time without disease symptoms coming back or extend patient's survival when compared to R-miniCHOP alone.
Recruiting1 award Phase 2 & 314 criteria

More about Catherine S. Diefenbach

Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Catherine S. Diefenbach has experience with
  • Rituximab
  • Nivolumab
  • Decitabine And Cedazuridine
  • Tafasitamab
  • CC-99282
  • Obinutuzumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Catherine S. Diefenbach specialize in?
Catherine S. Diefenbach focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are CCND1 positive.
Is Catherine S. Diefenbach currently recruiting for clinical trials?
Yes, Catherine S. Diefenbach is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Catherine S. Diefenbach has studied deeply?
Yes, Catherine S. Diefenbach has studied treatments such as Rituximab, Nivolumab, Decitabine and Cedazuridine.
What is the best way to schedule an appointment with Catherine S. Diefenbach?
Apply for one of the trials that Catherine S. Diefenbach is conducting.
What is the office address of Catherine S. Diefenbach?
The office of Catherine S. Diefenbach is located at: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York 10016 United States. This is the address for their practice at the Laura and Isaac Perlmutter Cancer Center at NYU Langone.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.